Newer Pharmacotherapies Compared With Triptans for Migraine Treatment
The analysis included 64 randomized clinical trials with a total of 46,442 patients.
Migraine
Qulipta Approved for Preventive Treatment of Episodic Migraine
Results from ADVANCE showed statistically significantly greater decreases in mean monthly migraine days with atogepant compared with placebo.
Trudhesa Nasal Spray Now Available for Acute Treatment of Migraine
Trudhesa uses proprietary technology to deliver a lower dose (0.725mg per spray) of dihydroergotamine mesylate to the upper nasal space.
Meloxicam/Rizatriptan Combo Under Review for Migraine Treatment
The application is supported by data from the phase 3 MOMENTUM and INTERCEPT trials.
High-Quality Diet Tied to Lower Migraine Frequency, Severity
Adherence to either DASH or Mediterranean dietary patterns tied to better migraine outcomes
Trudhesa Nasal Spray Approved for Acute Treatment of Migraine
The approval is supported by data from the phase 3 STOP 301 study, which evaluated the safety and tolerability of Trudhesa in 354 adults with migraine.
Exploring Aspirin for the Treatment and Prevention of Migraines
Aspirin has been effective for acute migraines both as a solitary modality and in combination with other drugs, and thus has clinical value in treatment and prophylaxis of the migraines overall.
Diet Rich in Omega 3 Fatty Acids Cuts Migraines in Adults
Diets with increased EPA, DHA with or without decrease in linoleic acid reduced headaches but did not significantly improve QOL
Study Compares Remote Electrical Neuromodulation to Migraine Meds in Adolescents
Nerivio is a wireless remote electrical neuromodulation device approved for the acute treatment of episodic or chronic migraine in patients 12 years of age and older.
Nurtec ODT Approval Expanded to Include Migraine Prevention
Rimegepant is an oral calcitonin gene-related peptide receptor antagonist.
